Viewing Study NCT05966467

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-05-18 @ 3:01 AM
Study NCT ID: NCT05966467
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2023-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuromyelitis Optica Spectrum Disorder View
None NMOSD View
None AQP4+ NMOSD View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neuromyelitis Optica Spectrum Disorder View
None NMOSD View
None C5 Inhibitor Therapies View
None AQP4+ NMOSD View
None Patient Registry View
None Alexion C5IT View
None Soliris View